A precision medicine company specialized in advancing high-quality therapies for patients living with age-related diseases successfully completed a capital raise valued at over EUR 40M through offerings to existing and select qualified investors.

The company enlisted the services of Trophic Communications to lead a media outreach project to receive coverage from important industry outlets with audiences comprising life science investors, the financial community at large and potential partners.

Trophic drafted the company’s press release announcing the capital raise to communicate the importance of the announcement to the company’s mid-stage clinical development plan and corporate goals, an important insight to future/current investors and the greater KOL community. Trophic compiled a list of key journalists in the general biotech, financial, and Aging-related conditions and established contact to pursue publication features and/or interviews with select members of the management team. Comprehensive media training was provided, an important component in providing team members with the necessary tools to better understand how journalists and editorial offices operate as well as the role social media plays in altering how information is distributed. Additionally, a compilation of all media coverage and social media analytics were accumulated and presented to the client for internal distribution and to analyze results of the campaign.

As a result of the collaborative efforts between Trophic and the company, the client received a significant increase in media coverage and features from notable publications in both the US and EU. The announcement was effectively distributed to garner attention from both the biotech media and investor communities, asserting the company’s position as a potential future leader in aging-related diseases.